Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar 1;78(3):321-328.
doi: 10.1001/jamaneurol.2020.4557.

Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone

Pierre Seners  1 , Wagih Ben Hassen  2 , Bertrand Lapergue  3 , Caroline Arquizan  4 , Mirjam R Heldner  5 , Hilde Henon  6 , Claire Perrin  1 , Davide Strambo  7 , Jean-Philippe Cottier  8 , Denis Sablot  9 , Isabelle Girard Buttaz  10 , Ruben Tamazyan  11 , Cécile Preterre  12 , Pierre Agius  12   13 , Nadia Laksiri  14 , Laura Mechtouff  15 , Yannick Béjot  16 , Duc-Long Duong  17 , François Mounier-Vehier  18 , Gioia Mione  19 , Charlotte Rosso  20 , Ludovic Lucas  21 , Jérémie Papassin  22   23 , Andreea Aignatoaie  24 , Aude Triquenot  25 , Emmanuel Carrera  26 , Philippe Niclot  27 , Alexandre Obadia  28 , Aïcha Lyoubi  29 , Pierre Garnier  30 , Nicolae Crainic  31 , Valérie Wolff  32 , Clément Tracol  33 , Frédéric Philippeau  34 , Chantal Lamy  35 , Sébastien Soize  36 , Jean-Claude Baron  1 , Guillaume Turc  1 ; MINOR-STROKE Collaborators
Collaborators, Affiliations
Observational Study

Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone

Pierre Seners et al. JAMA Neurol. .

Abstract

Importance: The best reperfusion strategy in patients with acute minor stroke and large vessel occlusion (LVO) is unknown. Accurately predicting early neurological deterioration of presumed ischemic origin (ENDi) following intravenous thrombolysis (IVT) in this population may help to select candidates for immediate transfer for additional thrombectomy.

Objective: To develop and validate an easily applicable predictive score of ENDi following IVT in patients with minor stroke and LVO.

Design, setting, and participants: This multicentric retrospective cohort included 729 consecutive patients with minor stroke (National Institutes of Health Stroke Scale [NIHSS] score of 5 or less) and LVO (basilar artery, internal carotid artery, first [M1] or second [M2] segment of middle cerebral artery) intended for IVT alone in 45 French stroke centers, ie, including those who eventually received rescue thrombectomy because of ENDi. For external validation, another cohort of 347 patients with similar inclusion criteria was collected from 9 additional centers. Data were collected from January 2018 to September 2019.

Main outcomes and measures: ENDi, defined as 4 or more points' deterioration on NIHSS score within the first 24 hours without parenchymal hemorrhage on follow-up imaging or another identified cause.

Results: Of the 729 patients in the derivation cohort, 335 (46.0%) were male, and the mean (SD) age was 70 (15) years; of the 347 patients in the validation cohort, 190 (54.8%) were male, and the mean (SD) age was 69 (15) years. In the derivation cohort, the median (interquartile range) NIHSS score was 3 (1-4), and the occlusion site was the internal carotid artery in 97 patients (13.3%), M1 in 207 (28.4%), M2 in 395 (54.2%), and basilar artery in 30 (4.1%). ENDi occurred in 88 patients (12.1%; 95% CI, 9.7-14.4) and was strongly associated with poorer 3-month outcomes, even in patients who underwent rescue thrombectomy. In multivariable analysis, a more proximal occlusion site and a longer thrombus were independently associated with ENDi. A 4-point score derived from these variables-1 point for thrombus length and 3 points for occlusion site-showed good discriminative power for ENDi (C statistic = 0.76; 95% CI, 0.70-0.82) and was successfully validated in the validation cohort (ENDi rate, 11.0% [38 of 347]; C statistic = 0.78; 95% CI, 0.70-0.86). In both cohorts, ENDi probability was approximately 3%, 7%, 20%, and 35% for scores of 0, 1, 2 and 3 to 4, respectively.

Conclusions and relevance: The substantial ENDi rates observed in these cohorts highlights the current debate regarding whether to directly transfer patients with IVT-treated minor stroke and LVO for additional thrombectomy. Based on the strong associations observed, an easily applicable score for ENDi risk prediction that may assist decision-making was derived and externally validated.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Lapergue has received grants from Stryker Neurovascular, Penumbra, MicroVention, and Balt. Dr Heldner has received grants from Bangerter Foundation and honoraria for serving on the scientific advisory board from Amgen. Dr Strambo has received grants from Swiss Heart Foundation and University of Lausanne. Dr Béjot has received personal fees from AstraZeneca, Bristol Myers Squibb, Pfizer, Medtronic, MSD France, Amgen, Servier Laboratories, and Boehringer Ingelheim. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Three-Month Modified Rankin Scale (mRS) Scores According to Early Neurological Deterioration of Presumed Ischemic Origin (ENDi) Status and Rescue Thrombectomy Status in the ENDi Subgroup in the Derivation Cohort
mRS score was not available for 37 patients (5 patients with ENDi and 32 with no early neurological deterioration [END]).
Figure 2.
Figure 2.. Early Neurological Deterioration of Presumed Ischemic Origin (ENDi) as a Function of Occlusion Site and Thrombus Length in the Derivation Cohort
A, ENDi rates according to each occlusion site. Error bars indicate 95% CIs. B, The regression curve estimates the probability of ENDi according to thrombus length. The shaded area depicts the 95% CIs (logistic regression model). END indicates early neurological deterioration; ICA-T/L, T or L intracranial internal carotid artery; M1, first segment of the middle cerebral artery; M2, second segment of the middle cerebral artery.
Figure 3.
Figure 3.. The ENDi Score for Prediction of Early Neurological Deterioration of Presumed Ischemic Origin (ENDi) in Patients With Minor Stroke Due to Intracranial Large Vessel Occlusion
A, ENDi risk prediction score. B, Probability of ENDi according to incremental points on the ENDi score applied to the derivation and validation cohorts. Incremental points are presented on the x-axis and probability of ENDi on the y-axis. Error bars indicate the 95% CIs. ICA-T/L indicates T or L intracranial internal carotid artery; M1, first segment of the middle cerebral artery; M2, second segment of the middle cerebral artery.
See this image and copyright information in PMC

Comment in

References

    1. Powers WJ, Rabinstein AA, Ackerson T, et al. ; American Heart Association Stroke Council . 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. doi:10.1161/STR.0000000000000158 - DOI - PubMed
    1. Mazya MV, Cooray C, Lees KR, et al. . Minor stroke due to large artery occlusion. when is intravenous thrombolysis not enough? results from the SITS International Stroke Thrombolysis Register. Eur Stroke J. 2018;3(1):29-38. doi:10.1177/2396987317746003 - DOI - PMC - PubMed
    1. Heldner MR, Jung S, Zubler C, et al. . Outcome of patients with occlusions of the internal carotid artery or the main stem of the middle cerebral artery with NIHSS score of less than 5: comparison between thrombolysed and non-thrombolysed patients. J Neurol Neurosurg Psychiatry. 2015;86(7):755-760. doi:10.1136/jnnp-2014-308401 - DOI - PubMed
    1. Heldner MR, Chaloulos-Iakovidis P, Panos L, et al. . Outcome of patients with large vessel occlusion in the anterior circulation and low NIHSS score. J Neurol. 2020;267(6):1651-1662. doi:10.1007/s00415-020-09744-0 - DOI - PubMed
    1. Seners P, Baron JC. Revisiting ‘progressive stroke’: incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke. J Neurol. 2018;265(1):216-225. doi:10.1007/s00415-017-8490-3 - DOI - PubMed

Publication types

MeSH terms

Substances